Literature DB >> 1433253

Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli.

P H Everest1, H Goossens, J P Butzler, D Lloyd, S Knutton, J M Ketley, P H Williams.   

Abstract

A collection of 44 Campylobacter isolates (37 C. jejuni and seven C. coli) from children with colitis (21 strains) or watery diarrhoea (23 strains) was analysed for toxin production, association with HeLa cells, and invasion of differentiated Caco-2 cell cultures. There was no obvious association of clinical symptoms with species, biotype or enterotoxin production. All colitis strains and most of the isolates from watery diarrhoea were cytotoxic for Chinese hamster ovary cells. Measurements of bacterial association indices with HeLa cells varied with time, and were considered to be unreliable for discriminating between isolates from the two diagnostic groups. Statistically significant differences were observed between the two groups (all colitis strains and 65% of strains from non-inflammatory diarrhoea) with respect to invasion of both HeLa and Caco-2 cell monolayers. However, among the strains from non-inflammatory diarrhoea that did invade, numbers of internalised bacteria were similar to the range observed for colitis strains. Of the colitis strains, 86% were able to transcytose through polarised Caco-2 monolayers grown on filters, compared with 48% of isolates from non-inflammatory disease. We propose the use of Caco-2 cells as a model for studying invasion of intestinal epithelia by C. jejuni and C. coli.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433253     DOI: 10.1099/00222615-37-5-319

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  63 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Detection on surfaces and in Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids.

Authors:  W G Miller; A H Bates; S T Horn; M T Brandl; M R Wachtel; R E Mandrell
Journal:  Appl Environ Microbiol       Date:  2000-12       Impact factor: 4.792

Review 3.  ppGpp conjures bacterial virulence.

Authors:  Zachary D Dalebroux; Sarah L Svensson; Erin C Gaynor; Michele S Swanson
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

4.  Enteric bacterial invasion of intestinal epithelial cells in vitro is dramatically enhanced using a vertical diffusion chamber model.

Authors:  Neveda Naz; Dominic C Mills; Brendan W Wren; Nick Dorrell
Journal:  J Vis Exp       Date:  2013-10-22       Impact factor: 1.355

Review 5.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

6.  Characterization of Campylobacter jejuni RacRS reveals roles in the heat shock response, motility, and maintenance of cell length homogeneity.

Authors:  Dmitry Apel; Jeremy Ellermeier; Mark Pryjma; Victor J Dirita; Erin C Gaynor
Journal:  J Bacteriol       Date:  2012-02-17       Impact factor: 3.490

7.  Diarrheal Mechanisms and the Role of Intestinal Barrier Dysfunction in Campylobacter Infections.

Authors:  Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

8.  Polyphosphate kinase 1 is a pathogenesis determinant in Campylobacter jejuni.

Authors:  Heather L Candon; Brenda J Allan; Cresson D Fraley; Erin C Gaynor
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

9.  Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin.

Authors:  M John Albert; Shilpa Haridas; Ben Adler
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

10.  Enhanced microscopic definition of Campylobacter jejuni 81-176 adherence to, invasion of, translocation across, and exocytosis from polarized human intestinal Caco-2 cells.

Authors:  Lan Hu; Ben D Tall; Sherill K Curtis; Dennis J Kopecko
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.